Drug
Oritavancin Diphosphate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Infusion Related Reaction | 67 | 71.7 | 92.3 | signal |
| 2 | Chills | 92 | 55.4 | 79.8 | signal |
| 3 | Feeling Cold | 17 | 43.1 | 45.6 | signal |
| 4 | Incorrect Product Administration Duration | 7 | 24.4 | 24.9 | signal |
| 5 | Flushing | 35 | 24.2 | 27.3 | signal |
| 6 | Skin Irritation | 8 | 12.3 | 12.6 | signal |